# Scopolamine in Bipolar Depression

> **NCT04211961** · PHASE2 · COMPLETED · sponsor: **Dr. Brian Hallahan** · enrollment: 55 (actual)

## Conditions studied

- Bipolar Disorder Depression

## Interventions

- **OTHER:** Placebo / Saline
- **DRUG:** Scopolamine

## Key facts

- **NCT ID:** NCT04211961
- **Lead sponsor:** Dr. Brian Hallahan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-23
- **Primary completion:** 2024-02-22
- **Final completion:** 2024-02-22
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2025-04-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04211961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04211961, "Scopolamine in Bipolar Depression". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04211961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*